Ronnie Aronson

10.3k total citations · 1 hit paper
94 papers, 3.7k citations indexed

About

Ronnie Aronson is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Genetics. According to data from OpenAlex, Ronnie Aronson has authored 94 papers receiving a total of 3.7k indexed citations (citations by other indexed papers that have themselves been cited), including 87 papers in Endocrinology, Diabetes and Metabolism, 31 papers in Surgery and 20 papers in Genetics. Recurrent topics in Ronnie Aronson's work include Diabetes Management and Research (71 papers), Diabetes Treatment and Management (62 papers) and Pancreatic function and diabetes (26 papers). Ronnie Aronson is often cited by papers focused on Diabetes Management and Research (71 papers), Diabetes Treatment and Management (62 papers) and Pancreatic function and diabetes (26 papers). Ronnie Aronson collaborates with scholars based in Canada, United States and France. Ronnie Aronson's co-authors include Ruth E. Brown, Julio Rosenstock, Elisabeth Niemoeller, Elisabeth Souhami, P. Miossec, Matthew C. Riddle, Lin Ping, Ronald Goldenberg, Harpreet S. Bajaj and Bo Åhrén and has published in prestigious journals such as The Lancet, Annals of Internal Medicine and The Journal of Immunology.

In The Last Decade

Ronnie Aronson

93 papers receiving 3.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Continuous Glucose Monitoring Versus Usual Care in Patients With Type 2 Diabetes Receiving Multiple Daily Insulin Injections

2017 449 citations Ronnie Aronson et al. profile →

Peers

Countries citing papers authored by Ronnie Aronson

Since Specialization

Citations

This map shows the geographic impact of Ronnie Aronson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ronnie Aronson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ronnie Aronson more than expected).

Fields of papers citing papers by Ronnie Aronson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ronnie Aronson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ronnie Aronson. The network helps show where Ronnie Aronson may publish in the future.

Co-authorship network of co-authors of Ronnie Aronson

This figure shows the co-authorship network connecting the top 25 collaborators of Ronnie Aronson. A scholar is included among the top collaborators of Ronnie Aronson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ronnie Aronson. Ronnie Aronson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Continuous glucose monitoring in noninsulin‐treated type 2 diabetes: A critical review of reported trials with an updated systematic review and meta‐analysis of randomised controlled trials 2025 ·Diabetes Obesity and Metabolism ·Ronnie Aronson, Alexander Abitbol, Harpreet S. Bajaj, Alice Cheng, Stavroula Christopoulos, Stewart B. Harris, (unknown), Ronald Goldenberg	1
2	Factors Associated With Attainment of Glycemic Targets Among Adults With Type 1 and Type 2 Diabetes in Canada: A Cross-sectional Study Using Primary and Specialty Care Electronic Medical Record Data 2023 ·Canadian Journal of Diabetes ·Alanna Weisman, Ruth E. Brown, (unknown), Ronnie Aronson, Bruce A. Perkins	4
3	Ultra rapid lispro showed greater reduction in postprandial glucose versus Humalog in children, adolescents and adults with type 1 diabetes mellitus 2023 ·Diabetes Obesity and Metabolism ·Ronnie Aronson, Torben Biester, Jennifer Leohr, Robyn K. Pollom, Helle Linnebjerg, Elizabeth LaBell, Qianyi Zhang, David E. Coutant, Thomas Danne	3
4	Randomized Comparison of Initiating the Fixed-Ratio Combination of iGlarLixi or Biosimilar Insulin Glargine Together With Gliclazide in Participants of South Asian Origin With Type 2 Diabetes: VARIATION 2 SA Trial 2022 ·Canadian Journal of Diabetes ·Harpreet S. Bajaj, (unknown), (unknown), Ruth E. Brown, (unknown), (unknown), (unknown), (unknown), Hasnain Khandwala, (unknown), Ronnie Aronson	7
5	Validation of a type 1 diabetes algorithm using electronic medical records and administrative healthcare data to study the population incidence and prevalence of type 1 diabetes in Ontario, Canada 2020 ·BMJ Open Diabetes Research & Care ·Alanna Weisman, Karen Tu, Jacqueline Young, Matthew Kumar, Peter C. Austin, Liisa Jaakkimainen, Lorraine L. Lipscombe, Ronnie Aronson, Gillian L. Booth	36
6	The Canadian LMC Diabetes Registry: A Profile of the Demographics, Management, and Outcomes of Individuals with Type 1 Diabetes 2020 ·Diabetes Technology & Therapeutics ·Ronnie Aronson, Ruth E. Brown, Alexander Abitbol, Ronald Goldenberg, Zeina Yared, Buki Ajala, Jean‐François Yale	19
7	Prevalence and Risk Evaluation of Diabetic Complications of the Foot Among Adults With Type 1 and Type 2 Diabetes in a Large Canadian Population (PEDAL Study) 2020 ·Canadian Journal of Diabetes ·Ronnie Aronson, (unknown), (unknown), Ruth E. Brown	14
8	Real-World Health Outcomes of Insulin Glargine 300 U/mL vs Insulin Glargine 100 U/mL in Adults With Type 1 and Type 2 Diabetes in the Canadian LMC Diabetes Patient Registry: The REALITY Study 2019 ·Canadian Journal of Diabetes ·Alexander Abitbol, Ruth E. Brown, (unknown), Luc Sauriol, Ronnie Aronson	13
9	Sodium Glucose Cotransporter-2 Inhibition and Cardiorenal Protection 2019 ·Journal of the American College of Cardiology ·David Z.I. Cherney, Ayodele Odutayo, Ronnie Aronson, Justin A. Ezekowitz, John D. Parker	58
10	Time Lag and Accuracy of Continuous Glucose Monitoring During High Intensity Interval Training in Adults with Type 1 Diabetes 2019 ·Diabetes Technology & Therapeutics ·Aihua Li, Michael C. Riddell, (unknown), Ruth E. Brown, Ronnie Aronson	30
11	Patient Reported Outcomes following initiation of Glucagon-like peptide-1 Receptor agonists in patients with type 2 Diabetes in a specialist endocrinology practice of the LMC diabetes registry: The PROGRESS-Diabetes study 2019 ·Diabetes Research and Clinical Practice ·Ruth E. Brown, Alexander Abitbol, Harpreet S. Bajaj, Ronald Goldenberg, Hasnain Khandwala, (unknown), Ronnie Aronson	10
12	The LMC Skills, Confidence & Preparedness Index (SCPI): development and evaluation of a novel tool for assessing self-management in patients with diabetes 2017 ·Health and Quality of Life Outcomes ·Lawrence Mbuagbaw, Ronnie Aronson, (unknown), Ruth E. Brown, (unknown)	8
13	Specialist-Led Diabetes Registries and Prevalence of Poor Glycemic Control in Type 2 Diabetes: The Diabetes Registry Outcomes Project for A1C Reduction (DROP A1C) 2016 ·Diabetes Care ·Ronnie Aronson, (unknown), Chenglin Ye, Ruth E. Brown, Ronald Goldenberg, Vivien Brown	23
14	OpT2mise: A Randomized Controlled Trial to Compare Insulin Pump Therapy with Multiple Daily Injections in the Treatment of Type 2 Diabetes—Research Design and Methods 2014 ·Diabetes Technology & Therapeutics ·Ronnie Aronson, Ohad Cohen, Ignacio Conget, (unknown), Javier Castañeda, Simona de Portu, Scott Lee, Yves Reznik, (unknown)	14
15	Insulin pump treatment compared with multiple daily injections for treatment of type 2 diabetes (OpT2mise): a randomised open-label controlled trial 2014 ·The Lancet ·Yves Reznik, Ohad Cohen, Ronnie Aronson, Ignacio Conget, (unknown), Javier Castañeda, Scott W. Lee	148
16	Insulin Pen Needles: Effects of Extra-Thin Wall Needle Technology on Preference, Confidence, and Other Patient Ratings 2013 ·Clinical Therapeutics ·Ronnie Aronson, Michael A. Gibney, (unknown), (unknown), Kenneth Kassler-Taub, Laurence Hirsch	35
17	Advances in Insulin Injection Research Influences Patient Adherence 2013 ·US Endocrinology ·Ronnie Aronson, Timothy S. Bailey, Laurence Hirsch, (unknown)	5
18	Efficacy and safety of lixisenatide once daily versus placebo in type 2 diabetes insufficiently controlled on pioglitazone ( GetGoal ‐P) 2013 ·Diabetes Obesity and Metabolism ·M. Pinget, Ronald Goldenberg, Elisabeth Niemoeller, Isabel Muehlen-Bartmer, Hailing Guo, Ronnie Aronson	123
19	The Role of Comfort and Discomfort in Insulin Therapy 2012 ·Diabetes Technology & Therapeutics ·Ronnie Aronson	66
20	Nodular Hyperplasia in Treated Congenital Goitrous Hypothyroidism 1996 ·Journal of Pediatric Endocrinology and Metabolism ·Ronnie Aronson, Etienne Sochett, Richard H. Pearl, Alan Daneman, Paul S. Thorner, Denis Daneman	4

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact